(Q42287592)

19 October 2017

title

Liposomal daunorubicin in advanced Kaposi's sarcoma: a phase II study (English)

1 reference

19 October 2017

1 reference

1 reference

Money-Kyrle JF

1

1 reference

19 October 2017

Bates F

2

1 reference

19 October 2017

Ready J

3

1 reference

19 October 2017

Gazzard BG

4

1 reference

19 October 2017

Phillips RH

5

1 reference

19 October 2017

Boag FC

6

1 reference

19 October 2017

publication date

1 January 1993

1 reference

19 October 2017

1 reference

19 October 2017

volume

5

1 reference

19 October 2017

issue

6

1 reference

19 October 2017

page(s)

367-371

1 reference

Intralesional vinblastine for oral Kaposi sarcoma in HIV infection

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980088-3

7 January 2021

Oral Kaposi's sarcoma in acquired immunodeficiency syndrome. Review of management and report of the efficacy of intralesional vinblastine

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980088-3

7 January 2021

Treatment of epidemic Kaposi's sarcoma with combination chemotherapy (vincristine and bleomycin) and zidovudine

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980088-3

7 January 2021

Treatment of Advanced Kaposiʼs Sarcoma Using a Combination of Bleomycin and Vincristine

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980088-3

7 January 2021

Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine.

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980088-3

7 January 2021

Advanced acquired immune deficiency syndrome-related Kaposi's sarcoma. Results of pilot studies using combination chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980088-3

7 January 2021

Systemic treatment of AIDS-related Kaposi's sarcoma: Results of a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980088-3

7 January 2021

A phase II study of 4'-epirubicin in the treatment of poor-risk Kaposi's sarcoma and AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980088-3

7 January 2021

Treatment of Kaposi's sarcoma with interferon alfa-2b (Intron A)

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980088-3

7 January 2021

Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS)

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980088-3

7 January 2021

In-111-labeled liposomes: dosimetry and tumor depiction

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980088-3

7 January 2021

Preliminary report: imaging of Kaposi sarcoma and lymphoma in AIDS with indium-111-labelled liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980088-3

7 January 2021

Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0936-6555%2805%2980088-3

7 January 2021

10.1016/S0936-6555(05)80088-3

Identifiers

DOI

1 reference

19 October 2017

1 reference